PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ABVC vs. QQQ
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between ABVC and QQQ is 0.05, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.0

Performance

ABVC vs. QQQ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ABVC Biopharma Inc (ABVC) and Invesco QQQ (QQQ). The values are adjusted to include any dividend payments, if applicable.

-40.00%-30.00%-20.00%-10.00%0.00%10.00%SeptemberOctoberNovemberDecember2025February
-35.00%
12.16%
ABVC
QQQ

Key characteristics

Sharpe Ratio

ABVC:

-0.77

QQQ:

1.44

Sortino Ratio

ABVC:

-1.33

QQQ:

1.95

Omega Ratio

ABVC:

0.86

QQQ:

1.26

Calmar Ratio

ABVC:

-0.65

QQQ:

1.94

Martin Ratio

ABVC:

-1.26

QQQ:

6.71

Ulcer Index

ABVC:

52.08%

QQQ:

3.92%

Daily Std Dev

ABVC:

84.93%

QQQ:

18.27%

Max Drawdown

ABVC:

-99.89%

QQQ:

-82.98%

Current Drawdown

ABVC:

-99.88%

QQQ:

0.00%

Returns By Period

In the year-to-date period, ABVC achieves a -22.63% return, which is significantly lower than QQQ's 5.27% return.


ABVC

YTD

-22.63%

1M

-15.46%

6M

-34.33%

1Y

-64.06%

5Y*

-57.85%

10Y*

N/A

QQQ

YTD

5.27%

1M

3.15%

6M

12.16%

1Y

25.73%

5Y*

18.66%

10Y*

18.37%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ABVC vs. QQQ — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ABVC
The Risk-Adjusted Performance Rank of ABVC is 99
Overall Rank
The Sharpe Ratio Rank of ABVC is 99
Sharpe Ratio Rank
The Sortino Ratio Rank of ABVC is 66
Sortino Ratio Rank
The Omega Ratio Rank of ABVC is 99
Omega Ratio Rank
The Calmar Ratio Rank of ABVC is 99
Calmar Ratio Rank
The Martin Ratio Rank of ABVC is 1212
Martin Ratio Rank

QQQ
The Risk-Adjusted Performance Rank of QQQ is 5757
Overall Rank
The Sharpe Ratio Rank of QQQ is 5757
Sharpe Ratio Rank
The Sortino Ratio Rank of QQQ is 5353
Sortino Ratio Rank
The Omega Ratio Rank of QQQ is 5656
Omega Ratio Rank
The Calmar Ratio Rank of QQQ is 6161
Calmar Ratio Rank
The Martin Ratio Rank of QQQ is 5858
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ABVC vs. QQQ - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for ABVC Biopharma Inc (ABVC) and Invesco QQQ (QQQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ABVC, currently valued at -0.77, compared to the broader market-2.000.002.004.00-0.771.44
The chart of Sortino ratio for ABVC, currently valued at -1.33, compared to the broader market-6.00-4.00-2.000.002.004.006.00-1.331.95
The chart of Omega ratio for ABVC, currently valued at 0.86, compared to the broader market0.501.001.502.000.861.26
The chart of Calmar ratio for ABVC, currently valued at -0.65, compared to the broader market0.002.004.006.00-0.651.94
The chart of Martin ratio for ABVC, currently valued at -1.26, compared to the broader market-10.000.0010.0020.0030.00-1.266.71
ABVC
QQQ

The current ABVC Sharpe Ratio is -0.77, which is lower than the QQQ Sharpe Ratio of 1.44. The chart below compares the historical Sharpe Ratios of ABVC and QQQ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00SeptemberOctoberNovemberDecember2025February
-0.77
1.44
ABVC
QQQ

Dividends

ABVC vs. QQQ - Dividend Comparison

ABVC has not paid dividends to shareholders, while QQQ's dividend yield for the trailing twelve months is around 0.53%.


TTM20242023202220212020201920182017201620152014
ABVC
ABVC Biopharma Inc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
QQQ
Invesco QQQ
0.53%0.56%0.62%0.80%0.43%0.55%0.74%0.91%0.84%1.06%0.99%1.41%

Drawdowns

ABVC vs. QQQ - Drawdown Comparison

The maximum ABVC drawdown since its inception was -99.89%, which is greater than QQQ's maximum drawdown of -82.98%. Use the drawdown chart below to compare losses from any high point for ABVC and QQQ. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-99.88%
0
ABVC
QQQ

Volatility

ABVC vs. QQQ - Volatility Comparison

ABVC Biopharma Inc (ABVC) has a higher volatility of 14.51% compared to Invesco QQQ (QQQ) at 5.01%. This indicates that ABVC's price experiences larger fluctuations and is considered to be riskier than QQQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%SeptemberOctoberNovemberDecember2025February
14.51%
5.01%
ABVC
QQQ
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab